Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

2-(3-(chloromethyl)benzoyloxy)benzoic Acid Increases CD4+ Regulatory T-Cell Population and FoxP3 Expression in Lipopolysaccharide-induced Mice

The Indonesian Biomedical Journal · Vol. 15 No. 4 (2023) · hlm. 339–346

DOI
10.18585/inabj.v15i4.2429
ISSN
2085-3297, 2355-9179
Terbit
2023-08-25
Penerbit
Secretariat of The Indonesian Biomedical Journal
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc/4.0/

Abstrak

BACKGROUND: Lipopolysaccharide (LPS) has been reported to increase CD4+ regulatory T-cell (CD4+ Treg) populations. Acetylsalicylic acid (ASA) has been reported to have immunomodulatory activity, but it may induce chronic gastric ulceration. Another salicylic acid-bearing compound, 2-(3-(chloromethyl)benzoyloxy)benzoic acid (3-CH2Cl), has been reported to have less gastric mucosal damage. However, the effect of 3-CH2Cl on CD4+ Tregs in LPS-induced mice is still unknown. Therefore, the present study was conducted to investigate the immunomodulatory effect of 3-CH2Cl on CD4+ T-cell and CD4+ Treg populations as well as FoxP3 expression in LPS-induced mice.METHODS: Synthesis of 3-CH2Cl was performed by mixing salicylic acid and chloromethylbenzoylchloride with the catalyzation of pyridine, acetone and heat. The 3-CH2Cl tablets were prepared using direct compression method. After intraperitoneal injection of 1 mg/kg BW LPS to mice, 60 mg/kg BW ASA or 60 mg/kg BW 3-CH2Cl was given orally for 3 days. The splenocyte was obtained through splenectomy and collagenase digestion. The population of CD4+ T-cells and CD4+ Tregs, as well as the splenic FoxP3 expression were determined using flow cytometry technique.RESULTS: CD4+ T-cell populations in mice treated with LPS and 3-CH2Cl or ASA were lower than those treated with LPS merely. Meanwhile, CD4+ Treg populations and FoxP3 expression levels in mice treated with LPS and 3-CH2Cl or ASA were higher than those treated with LPS merely.CONCLUSION: Since 3-CH2Cl could decrease CD4+ T-cell population and increase CD4+ Treg population mediated by the increase of FoxP3 expression in LPS-induced inflammation, it may act as a potential therapeutic drug to reduce inflammatory conditions.KEYWORDS: 2-(3-(chloromethyl)benzoyloxy)benzoic acid, acetylsalicylic acid, CD4, T-regulatory cells, FoxP3, LPS

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 194 tautan kepenulisan bersama · 104 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Katolik Widya Mandala Surabaya
  • Universitas Gadjah Mada
  • Universitas Airlangga
  • University of Würzburg
  • University of Brawijaya
  • Universitas Ibrahimy
  • Rumah Sakit Dokter Soetomo
  • Organisasi lain
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Ulayatul KustiatiUniversity of Brawijaya8
Bernadette Dian NovitaUniversitas Katolik Widya Mandala Surabaya7
Sianty DewiUniversitas Katolik Widya Mandala Surabaya7
I Gede Putu Adhi WedhargaUniversitas Katolik Widya Mandala Surabaya5
Martha ErvinaUniversitas Katolik Widya Mandala Surabaya5
Widya WasityastutiUniversitas Gadjah Mada5
Suryo KuncorojaktiUniversitas Airlangga4
Dewi Ratih Tirto SariUniversitas Ibrahimy4
Dinda AliffiaUniversitas Gadjah Mada4
Nastiti WijayantiUniversitas Gadjah Mada3
Aris Tri HaryantoUniversitas Gadjah Mada3
Teguh BudipitojoUniversitas Gadjah Mada2
Ahmad Hamim SadewaUniversitas Gadjah Mada2
Muhammad AminuddinRumah Sakit Dokter Soetomo2
Paulus Budiono NotopuroUniversitas Airlangga2
Abdul Hafid BajamalUniversitas Airlangga2
Valentinus BesinUniversity of Surabaya2
Mohammad Hasan MachfoedUniversitas Airlangga2
Tri Wahyu PangestiningsihUniversitas Gadjah Mada2
Christantie EffendyUniversitas Gadjah Mada1
Andina SetyawatiHasanuddin University1
Mae Sri Hartati WahyuningsihUniversitas Gadjah Mada1
Sam Chidi IbenemeUniversity of Nigeria1
Etty Puji LestariIndonesia Open University1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764892910, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">2-(3-(chloromethyl)benzoyloxy)benzoic Acid Increases CD4+ Regulatory T-Cell Population and FoxP3 Expression in Lipopolysaccharide-induced Mice</dc:title><dc:creator>Yudy Tjahjono</dc:creator><dc:creator>Caroline Caroline</dc:creator><dc:creator>Jusak Nugraha</dc:creator><dc:creator>Kuncoro Foe</dc:creator><dc:creator>Srikanth Karnati</dc:creator><dc:creator>Süleyman Ergün</dc:creator><dc:creator>Nico Jafet</dc:creator><dc:creator>Oryza Chrisantia</dc:creator><dc:creator>I Made Andika Bara Kusuma</dc:creator><dc:creator>Hendy Wijaya</dc:creator><dc:creator>Wuryanto Hadinugroho</dc:creator><dc:creator>Dwi Aris Agung Nugrahaningsih</dc:creator><dc:creator>Dwi Liliek Kusindarta</dc:creator><dc:creator>Yufita Ratnasari Wilianto</dc:creator><dc:creator>Senny Yesery Esar</dc:creator><dc:creator>Hevi Wihadmadyatami</dc:creator><dc:subject>aspirin</dc:subject><dc:subject>CD4+ regulatory T cells</dc:subject><dc:subject>Foxp3</dc:subject><dc:subject>lipopolysaccharide-induced inflammation</dc:subject><dc:subject>immunomodulation</dc:subject><dc:subject>salicylates</dc:subject><dc:subject>anti-inflammatory agents</dc:subject><dc:subject>gastric mucosal injury</dc:subject><dc:subject>splenocytes</dc:subject><dc:description xml:lang="en">BACKGROUND: Lipopolysaccharide (LPS) has been reported to increase CD4+ regulatory T-cell (CD4+ Treg) populations. Acetylsalicylic acid (ASA) has been reported to have immunomodulatory activity, but it may induce chronic gastric ulceration. Another salicylic acid-bearing compound, 2-(3-(chloromethyl)benzoyloxy)benzoic acid (3-CH2Cl), has been reported to have less gastric mucosal damage. However, the effect of 3-CH2Cl on CD4+ Tregs in LPS-induced mice is still unknown. Therefore, the present study was conducted to investigate the immunomodulatory effect of 3-CH2Cl on CD4+ T-cell and CD4+ Treg populations as well as FoxP3 expression in LPS-induced mice.METHODS: Synthesis of 3-CH2Cl was performed by mixing salicylic acid and chloromethylbenzoylchloride with the catalyzation of pyridine, acetone and heat. The 3-CH2Cl tablets were prepared using direct compression method. After intraperitoneal injection of 1 mg/kg BW LPS to mice, 60 mg/kg BW ASA or 60 mg/kg BW 3-CH2Cl was given orally for 3 days. The splenocyte was obtained through splenectomy and collagenase digestion. The population of CD4+ T-cells and CD4+ Tregs, as well as the splenic FoxP3 expression were determined using flow cytometry technique.RESULTS: CD4+ T-cell populations in mice treated with LPS and 3-CH2Cl or ASA were lower than those treated with LPS merely. Meanwhile, CD4+ Treg populations and FoxP3 expression levels in mice treated with LPS and 3-CH2Cl or ASA were higher than those treated with LPS merely.CONCLUSION: Since 3-CH2Cl could decrease CD4+ T-cell population and increase CD4+ Treg population mediated by the increase of FoxP3 expression in LPS-induced inflammation, it may act as a potential therapeutic drug to reduce inflammatory conditions.KEYWORDS: 2-(3-(chloromethyl)benzoyloxy)benzoic acid, acetylsalicylic acid, CD4, T-regulatory cells, FoxP3, LPS</dc:description><dc:publisher>Secretariat of The Indonesian Biomedical Journal</dc:publisher><dc:date>2023-08-25</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.18585/inabj.v15i4.2429</dc:identifier><dc:identifier>10.18585/inabj.v15i4.2429</dc:identifier><dc:source>The Indonesian Biomedical Journal; Vol 15 No 4 (2023); 339-346</dc:source><dc:source>2085-3297</dc:source><dc:source>2355-9179</dc:source><dc:language>en</dc:language><dc:relation>https://inabj.org/index.php/ibj/article/download/2429/655</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc/4.0/</dc:rights></oai_dc:dc>